Lamotrigin Heumann

Lamotrigine, the active ingredient in Lamotrigin Heumann, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat epilepsy, prevent seizure recurrence, and manage bipolar disorder in adults and adolescents.

GNH USA supplies Lamotrigin Heumann as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamotrigine is an anticonvulsant that acts on neuronal excitability in several neurological and psychiatric conditions.

- Epilepsy: Reduces the frequency of partial and generalized seizures. - Bipolar disorder: Stabilizes mood and decreases the risk of manic or depressive episodes. - Seizure prophylaxis: Provides ongoing prevention of seizure recurrence after initial control.

Lamotrigine may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Nausea: feeling of stomach upset or urge to vomit. - Rash: mild skin redness or itching. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction with blistering. - Toxic epidermal necrolysis: life‑threatening skin detachment. - Aseptic meningitis: inflammation of the meninges without infection. - Blood dyscrasias: such as agranulocytosis or aplastic anemia. - Hepatic failure: severe liver injury.

When prescribing lamotrigine, clinicians should consider several safety precautions to minimize risks. - Pregnancy: Category D; use only if benefits outweigh potential fetal risks. - Skin reactions: Monitor for rash; discontinue if signs of Stevens‑Johnson syndrome appear. - Renal impairment: Adjust dosing in patients with severe kidney dysfunction. - Hepatic impairment: Use caution and consider dose reduction in liver disease. - Concomitant valproate: Anticipate increased lamotrigine levels; monitor closely. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture.

Lamotrigine interacts with several medicines that can alter its plasma concentration or increase toxicity.

Major Interactions (Avoid): - Valproic acid: markedly raises lamotrigine levels; avoid co‑administration without dose adjustment. - Carbamazepine: reduces lamotrigine concentrations, potentially decreasing efficacy. - Phenytoin: accelerates lamotrigine metabolism, leading to subtherapeutic levels.

Moderate Interactions (Monitor Closely): - Oral contraceptives: may lower lamotrigine levels, requiring dose review. - Phenobarbital: induces metabolism, decreasing lamotrigine exposure. - Serotonergic agents: combined use may increase risk of serotonin syndrome, monitor symptoms.